Salesforce (CRM)
(Delayed Data from NYSE)
$274.29 USD
+1.15 (0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $274.49 +0.20 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$274.29 USD
+1.15 (0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $274.49 +0.20 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Zacks News
Zacks.com featured highlights include: Nexstar Media Group Inc. , Universal Health Services Inc. , salesforce.com, W.W. Grainger Inc. and Marvell Technology
by Zacks Equity Research
Nexstar Media Group Inc. , Universal Health Services Inc. , salesforce.com, W.W. Grainger Inc. and Marvell Technology are highlighted in this screen of the week article.
Here's Why Salesforce (CRM) Stock Plunged 8.3% Today
by Madeleine Johnson
Cloud-based software giant Salesforce (CRM) closed down over 8% on Wednesday after UBS analyst Karl Keirstead cut his rating and price target on the stock.
NVIDIA's (NVDA) DRIVE Orin SoC to Power TuSimple's ADC Unit
by Zacks Equity Research
NVIDIA (NVDA) collaborates with San Diego-based autonomous driving tech company, TuSimple, to develop and design advanced ADC by incorporating its DRIVE Orin SoC.
Ambarella (AMBA) Introduces CV3 AI Domain Controller SoC
by Zacks Equity Research
Ambarella (AMBA) launches CV3 AI domain controller SoC for implementing autonomous driving for vehicles from Level 2+ to Level 4.
Solid Sales Growth Makes These 5 Stocks Worth Buying Now
by Swayta Shah
Robust sales growth is vital to gauge a company's ability to sustain its business. Let's check out Nexstar Media (NXST), Universal Health (UHS), salesforce.com (CRM), Grainger (GWW) and Marvell (MRVL), as these witness top-line growth.
ANSYS' (ANSS) Simulation Solutions Leveraged by Innoviz
by Zacks Equity Research
ANSYS (ANSS) simulation software offerings implemented by Innoviz to advance work on automotive-grade LiDAR sensor technology.
Markets Trade Mixed; Dow Sets New Record, Nasdaq Drop 200 Points
by Mark Vickery
A 10-year Treasury yield cresting upward past 1.68% midday -- close to highs in this cycle -- is seen as a catalyst for this action.
Blackbaud (BLKB) Buys EVERFI for $750M: Major Takeaways
by Zacks Equity Research
Blackbaud's (BLKB) EVERFI acquisition expands the company's total addressable market to more than $20 billion
NVIDIA (NVDA) Up 125% Last Year: Will Rally Continue in 2022?
by Zacks Equity Research
NVIDIA (NVDA) stock is likely to continue the upward momentum as the company is benefiting from strong graphic chip demand across multiple end markets.
The Zacks Analyst Blog Highlights: The Home Depot Inc., Emerson Electric Co., salesforce.com inc., Lowe's Companies Inc. and Marvell Technology Inc.
by Zacks Equity Research
The Home Depot Inc., Emerson Electric Co., salesforce.com inc., Lowe's Companies Inc. and Marvell Technology Inc. are highlighted in this analyst blog.
Apple's (AAPL) In-App Purchase Policy to be Probed by CCI
by Zacks Equity Research
Apple's (AAPL) compulsory in-app purchase system is to be investigated by India's CCI. This has been ordered after a Jaipur-based NPO filed a complaint against the company's App Store payment rules.
3 Reasons Why Wall Street Bulls Will Roar in 2022
by Nalak Das
It will be prudent to invest in U.S. corporate giants with a favorable Zacks Rank to tap the market rally in 2022. Here are five of them: HD, LOW, MRVL, EMR and CRM.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $254.13 in the latest trading session, marking a -0.47% move from the prior day.
Fortinet (FTNT) Up 142% YTD: Will the Rally Continue in 2022?
by Zacks Equity Research
Fortinet (FTNT) stock is likely to continue upward momentum as the company sees solid demand for its security and networking products amid the ongoing pandemic crisis and remote working trend.
BlackBerry (BB) is an Enticing Bet for Investors: Here's Why
by Zacks Equity Research
Robust demand for cybersecurity and IoT products, accretive design wins and partnerships with major players on the back of a holistic growth model bode well for BlackBerry (BB).
Why Is Salesforce.com (CRM) Up 1.2% Since Last Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Much Upside is Left in Salesforce.com (CRM)? Wall Street Analysts Think 27%
by Zacks Equity Research
The mean of analysts' price targets for Salesforce.com (CRM) points to a 26.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Tyler (TYL) Acquires University Inn Academic Suites Building
by Zacks Equity Research
Tyler (TYL) purchases University Inn Academic Suites building in Orono, Maine, to hire local talents and enhance job opportunities in STEAM fields across the town.
Mercury Systems (MRCY) Implements Poison-Pill Tactic for 1-Year
by Zacks Equity Research
Mercury Systems (MRCY) adopts one-year shareholder rights plan, commonly known as Poison Pill, to protect the long-term interests of its shareholders.
Reasons to Hold DocuSign (DOCU) Stock in Your Portfolio
by Zacks Equity Research
DocuSign (DOCU) is increasing investments in global sales capacity, training and field enablement to expand its pipeline of new businesses.
The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin
Top Research Reports for salesforce, Intuit & Bristol-Myers
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including salesforce.com, inc. (CRM), Intuit Inc. (INTU), and Bristol-Myers Squibb Company (BMY).
CDW Stock Surges 57% YTD: Will the Rally Continue in 2022?
by Zacks Equity Research
CDW Corporation (CDW) stock likely to continue upward momentum as the company witnesses solid demand for its products that enable remote working and operations continuity plans, thus boosting revenue growth for certain products.
Should You Invest in the iShares Expanded TechSoftware Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Santa Claus Rally Underway
by Mark Vickery
For the second-straight trading day, the S&P 500 has notched another all-time closing high.